Tirzepatide 10mg Research Peptide

Tirzepatide is a synthetic dual incretin receptor agonist research compound that has gained significant interest within scientific research communities for its role in metabolic pathway studies, glucose regulation research, appetite signalling investigations, and energy balance research.

As a dual GIP and GLP-1 receptor agonist, Tirzepatide is studied for its interaction with key metabolic hormone pathways involved in insulin signalling, nutrient regulation, and physiological processes related to metabolism. Research has explored its role in areas including glucose metabolism, body composition, appetite pathways, and metabolic health mechanisms.

Dual GIP / GLP-1 Receptor Agonist Research Compound

Tirzepatide is investigated as a research compound for understanding incretin hormone activity and its relationship with metabolic regulation. By targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, it provides researchers with a unique model for studying interconnected pathways involved in energy balance, glucose homeostasis, and metabolic signalling.

Key Research Applications

• GIP and GLP-1 receptor signalling studies
• Incretin pathway and metabolic regulation research
• Glucose metabolism and insulin response investigations
• Appetite signalling and food intake pathway studies
• Body composition and energy balance research
• Lipid metabolism and metabolic marker investigations
• Comparative research alongside other peptide-based metabolic compounds

Potential Research Benefits

• Studied for its role in dual incretin receptor activation and metabolic signalling
• Investigated for its involvement in glucose regulation pathways
• Explored in research examining appetite-related signalling mechanisms
• Examined for its relationship with energy balance and metabolic processes
• Used in studies investigating insulin pathway activity and hormone interactions
• Researched as part of broader investigations into obesity, metabolism, and endocrine function
• Evaluated in comparative research involving GLP-1-based and multi-pathway metabolic compounds

Product Information

• Strength: 10mg per vial
• Tirzepatide research peptide
• Lyophilised (freeze-dried) laboratory compound
• High-purity research grade
• Batch-specific Certificate of Analysis (CoA) available
• Fast Australia-wide shipping

Important Notice

This product is supplied strictly for laboratory and in-vitro research purposes only.

Not for human consumption. Not intended for therapeutic, diagnostic, veterinary, or clinical use.